- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 42
- Scientists listed
- 0
- Grants since 2016
- 3
Grants received
2020–2023 · research · R01
A Phase 3 Study of Emixustat Hydrochloride for Stargardt Disease IND 101,084 (02/11/2019)
Ryo Kubota · Acucela (United States) · funded by U.S. Food and Drug Administration
2020–2023 · research · R01
A Phase 3 Study of Emixustat Hydrochloride for Stargardt Disease IND 101,084 (02/11/2019)
Ryo Kubota · Acucela (United States) · funded by U.S. Food and Drug Administration
2020–2023 · research · R01
A Phase 3 Study of Emixustat Hydrochloride for Stargardt Disease IND 101,084 (02/11/2019)
Ryo Kubota · Acucela (United States) · funded by U.S. Food and Drug Administration
